Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuro Endocrine Tumours”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableLooking for participantsNCT04880356
What this trial is testing

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

Who this might be right for
Inherited DiseaseRare DiseasesMetabolic Disease+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 100
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Not applicableStudy completedNCT02651246
What this trial is testing

Optional Sub-study to Intraoperative Imaging With ICG Registry

Who this might be right for
Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) CancerCancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma CancerCancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer
Abramson Cancer Center at Penn Medicine 291
Post-approval studies (Phase 4)WithdrawnNCT02779257
What this trial is testing

Pasireotide Treatment for Neuroendocrine Tumor

Who this might be right for
Gastro-enteropancreatic Neuroendocrine Tumor
University of Maryland, Baltimore
Not applicableLooking for participantsNCT06856902
What this trial is testing

BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe

Who this might be right for
Cardiovascular DiseasesEndocrinologyInmunology+3 more
Technical University of Madrid 3,100
Not applicableLooking for participantsNCT06043193
What this trial is testing

Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.

Who this might be right for
Metastatic Neuroendocrine Tumour
Hospices Civils de Lyon 100
Large-scale testing (Phase 3)Study completedNCT03590119
What this trial is testing

Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases

Who this might be right for
Neuroendocrine TumorsLiver Metastases
Marnix Lam 26
Not applicableStudy completedNCT02134639
What this trial is testing

PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation

Who this might be right for
Neuroendocrine Tumors
University Hospital, Bordeaux 20
Not applicableUnknownNCT03958188
What this trial is testing

PreOPerative Imaging of NeuroEndocrine Tumors

Who this might be right for
Neuro-endocrine TumorsSmall Intestine Cancer
Hospices Civils de Lyon 47
Not applicableLooking for participantsNCT05013944
What this trial is testing

AnovaOS Network Powered Patient Registry

Who this might be right for
Infectious DiseaseNeoplasmsDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)+18 more
Anova Enterprises, Inc 100,000
Testing effectiveness (Phase 2)Study completedNCT00688623
What this trial is testing

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe

Who this might be right for
Advanced and Metastatic Silent Neuro-Endocrine TumorsCarcinomaNeuroendocrine+4 more
Novartis Pharmaceuticals 73
Not applicableStudy completedNCT01398306
What this trial is testing

Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.

Who this might be right for
CarcinomaCarcinoma, Renal CellNeuroendocrine Tumors+2 more
University Medical Center Groningen 40
Post-approval studies (Phase 4)Ended earlyNCT04140409
What this trial is testing

Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation

Who this might be right for
Neuroendocrine TumorsCarcinoid Syndrome
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 10
Not applicableEnded earlyNCT04452396
What this trial is testing

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Who this might be right for
Hypoglycemia, ReactiveHypoglycaemia NightHypoglycemia Non-Diabetic+7 more
Barts & The London NHS Trust 7
Post-approval studies (Phase 4)Looking for participantsNCT07262957
What this trial is testing

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Who this might be right for
Pancreas Head CancerPancreas AdenocarcinomaIPMN, Pancreatic+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 400
Not applicableStudy completedNCT07105553
What this trial is testing

Glove Compression for Chemotherapy-Induced Neuropathy

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy (CIPN)Gynecologic CancersOvarian Cancer (OvCa)+1 more
Ankara Etlik City Hospital 76
Not applicableUnknownNCT03526809
What this trial is testing

Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology

Who this might be right for
Ovarian Cancer
Cambridge University Hospitals NHS Foundation Trust 40
Not applicableEnrolling By InvitationNCT03197363
What this trial is testing

Białystok PLUS - Polish Longitudinal University Study

Who this might be right for
Cardiovascular DiseasesDiabetesNeuro-Degenerative Disease+3 more
Medical University of Bialystok 10,000
Large-scale testing (Phase 3)Study completedNCT02840149
What this trial is testing

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Jewish General Hospital 45
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Load More Results